SpliceTools
SpliceTools analyzes transcriptome-wide alternative splicing (AS) from RNA sequencing (RNA-seq) data to generate summary statistics, provide mechanistic insights, and assess functional consequences.
Key Features:
- Data Processing Modules: Includes modules that streamline analysis of large RNA-seq datasets to derive interpretable splicing results.
- Summary Statistics: Produces summary statistics of alternative splicing events across samples and experimental conditions.
- Mechanistic Insights: Distinguishes splicing disruptions from regulated transcript isoform changes and aids interpretation of splicing inhibition mechanisms.
- Functional Impact Assessment: Assesses functional consequences of AS events, including effects on cell cycle progression.
Scientific Applications:
- Pharmacologic Studies: Analyzes the transcriptome footprint of pharmacologic splicing inhibitors such as indisulam and helps identify predicted neo-epitopes arising from such interventions.
- Gene Knockdown and NMD Inhibition: Applied to RNA binding protein knockdowns (including a dataset of 186 knockdowns) and nonsense-mediated RNA decay (NMD) inhibition to study AS dynamics.
Methodology:
Analyzes RNA-seq datasets from experimental conditions including 186 RNA binding protein knockdowns, nonsense-mediated RNA decay inhibition, and pharmacologic splicing inhibition to characterize AS events across biological contexts.
Topics
Details
- License:
- GPL-3.0
- Cost:
- Free of charge
- Tool Type:
- desktop application, web application
- Operating Systems:
- Mac, Linux, Windows
- Programming Languages:
- Perl
- Added:
- 9/19/2023
- Last Updated:
- 11/24/2024
Operations
Data Inputs & Outputs
Alternative splicing prediction
Publications
Flemington EK, Flemington SA, O’Grady TM, Baddoo M, Nguyen T, Dong Y, Ungerleider NA. SpliceTools, a suite of downstream RNA splicing analysis tools to investigate mechanisms and impact of alternative splicing. Nucleic Acids Research. 2023;51(7):e42-e42. doi:10.1093/nar/gkad111. PMID:36864749. PMCID:PMC10123099.